
Bruker (BRKR) Stock Forecast & Price Target
Bruker (BRKR) Analyst Ratings
Bulls say
Bruker Corp is forecasting adjusted earnings per share (EPS) growth between 0% to 3% as reported, or 5% to 8% on a constant currency basis, indicating a resilience in profitability despite a downward revision from earlier expectations. The company reported an improvement in adjusted gross margins by 10 basis points to 51.3%, highlighting effective cost management and operational efficiency. Additionally, management anticipates a recovery in fiscal year 2026, post Tariff and Administrative & General (A&G) impacts, which supports a positive outlook for future growth.
Bears say
Bruker Corp has lowered its operating margin expectations for FY25 to flat, a significant drop from a prior forecast of an increase of 140 basis points, reflecting concerns about profitability. Additionally, management anticipates a decline in organic revenue for the second quarter due to softer conditions in the U.S. and China, along with delays in U.S.-produced revenue. Furthermore, the company's 2025 outlook for organic growth has been reduced to a range of 0% to 2%, falling short of Street expectations and indicating potential stagnation in core operations.
This aggregate rating is based on analysts' research of Bruker and is not a guaranteed prediction by Public.com or investment advice.
Bruker (BRKR) Analyst Forecast & Price Prediction
Start investing in Bruker (BRKR)
Order type
Buy in
Order amount
Est. shares
0 shares